Talks at GS

Goldman Sachs’ culture has long been defined by its core values: partnership, client service, integrity, and excellence. Lloyd Blankfein, Senior Chairman of The Goldman Sachs Group Inc. and former Chairman and CEO of Goldman Sachs, joins David Solomon, current Chairman and CEO of Goldman Sachs for a conversation on his storied career and the launch of his memoir, Streetwise: Getting to and Through Goldman Sachs. Lloyd reflects on his upbringing in Brooklyn, path to Harvard, long-time leadership at Goldman Sachs, the evolution of the firm’s partnership culture, and the critical risk management lessons learned while steering the firm through the 2008 financial crisis and its aftermath.

This episode was recorded on February 25, 2026.

The opinions and views expressed herein are as of the date of publication, subject to change without notice, and may not necessarily reflect the institutional views of Goldman Sachs or its affiliates. The material provided is intended for informational purposes only, and does not constitute investment advice, a recommendation from any Goldman Sachs entity to take any particular action, or an offer or solicitation to purchase or sell any securities or financial products. This material may contain forward-looking statements. Past performance is not indicative of future results. Neither Goldman Sachs nor any of its affiliates make any representations or warranties, express or implied, as to the accuracy or completeness of the statements or information contained herein and disclaim any liability whatsoever for reliance on such information for any purpose. Each name of a third-party organization mentioned is the property of the company to which it relates, is used here strictly for informational and identification purposes only and is not used to imply any ownership or license rights between any such company and Goldman Sachs.

A transcript is provided for convenience and may differ from the original video or audio content. Goldman Sachs is not responsible for any errors in the transcript. This material should not be copied, distributed, published, or reproduced in whole or in part or disclosed by any recipient to any other person without the express written consent of Goldman Sachs.

Disclosures applicable to research with respect to issuers, if any, mentioned herein are available through your Goldman Sachs representative or at http://www.gs.com/research/hedge.html

Goldman Sachs does not endorse any candidate or any political party.

Copyright 2026. All rights reserved.

Learn more about your ad choices. Visit megaphone.fm/adchoices

Board governance is central to how companies earn and maintain trust with shareholders and the public. Larry Cunningham, Presiding Director of the John L. Weinberg Center for Corporate Governance at the University of Delaware, joins John F.W. Rogers, Secretary of the Board of Directors at Goldman Sachs, to discuss the evolution of board stewardship and its importance today. Cunningham discusses the Center’s 25th anniversary and the discovery of John L. Weinberg’s 1948 Princeton thesis on the status and functions of corporate directors. They explore enduring governance questions including shareholder focus versus broader corporate responsibilities, the value of discerning questions, and why one-size-fits-all governance checklists often miss what matters most. This episode was recorded on October 27, 2025. 

The opinions and views expressed herein are as of the date of publication, subject to change without notice, and may not necessarily reflect the institutional views of Goldman Sachs or its affiliates. The material provided is intended for informational purposes only, and does not constitute investment advice, a recommendation from any Goldman Sachs entity to take any particular action, or an offer or solicitation to purchase or sell any securities or financial products. This material may contain forward-looking statements. Past performance is not indicative of future results. Neither Goldman Sachs nor any of its affiliates make any representations or warranties, express or implied, as to the accuracy or completeness of the statements or information contained herein and disclaim any liability whatsoever for reliance on such information for any purpose. Each name of a third-party organization mentioned is the property of the company to which it relates, is used here strictly for informational and identification purposes only and is not used to imply any ownership or license rights between any such company and Goldman Sachs.

A transcript is provided for convenience and may differ from the original video or audio content. Goldman Sachs is not responsible for any errors in the transcript. This material should not be copied, distributed, published, or reproduced in whole or in part or disclosed by any recipient to any other person without the express written consent of Goldman Sachs. Disclosures applicable to research with respect to issuers, if any, mentioned herein are available through your Goldman Sachs representative or at http://www.gs.com/research/hedge.html

Goldman Sachs does not endorse any candidate or any political party.

© 2026 Goldman Sachs. All rights reserved.

Learn more about your ad choices. Visit megaphone.fm/adchoices

Adyen has scaled from an Amsterdam startup to a global fintech by building every layer of payments in-house and focusing relentlessly on merchants. Pieter van der Does, co-founder and co-CEO of Adyen, joins Clif Marriott, co-head of Technology, Media and Telecoms in EMEA at Goldman Sachs, to discuss Adyen's origin story, the strategy that helped Adyen scale to roughly $900 billion in annual processed volume, and a winning company culture that fosters global collaboration. This session was recorded in London on November 5, 2025. 

The opinions and views expressed herein are as of the date of publication, subject to change without notice and may not necessarily reflect the institutional views of Goldman Sachs or its affiliates. The material provided is intended for informational purposes only and does not constitute investment advice, a recommendation from any Goldman Sachs entity to take any particular action, or an offer or solicitation to purchase or sell any securities or financial products. This material may contain forward-looking statements. Past performance is not indicative of future results. Neither Goldman Sachs nor any of its affiliates make any representations or warranties, expressed or implied, as to the accuracy or completeness of the statements or information contained herein and disclaim any liability whatsoever for reliance on such information for any purpose. Each name of a third-party organization mentioned is the property of the company to which it relates is used here strictly for informational and identification purposes only and is not used to imply any ownership or license rights between any such company and Goldman Sachs.

A transcript is provided for convenience and may differ from the original video or audio content. Goldman Sachs is not responsible for any errors in the transcript. This material should not be copied, distributed, published, or reproduced in whole or in part or disclosed by any recipient to any other person without the express written consent of Goldman Sachs.

Disclosures applicable to research with respect to issuers, if any, mentioned herein are available through your Goldman Sachs representative or at www.GS.com/research/hedge.html.

Copyright 2026, Goldman Sachs, all rights reserved.

Learn more about your ad choices. Visit megaphone.fm/adchoices

Poppi began as a kitchen experiment with apple cider vinegar and has grown into a leading beverage brand, which was recently acquired by PepsiCo for nearly $2 billion. Allison and Stephen Ellsworth, co-founders of Poppi, joined Vanya Kasanof to share the brand’s journey to becoming a digital-first sensation and a category leader. They discuss Poppi’s rapid rise, the power of intuition and culture, and how a relentless focus on brand and community propelled them from farmers markets to a landmark Super Bowl ad. This session was recorded at the 2025 Goldman Sachs Builders and Innovators Summit on October 15, 2025.

The opinions and views expressed herein are as of the date of publication, subject to change without notice and may not necessarily reflect the institutional views of Goldman Sachs or its affiliates. The material provided is intended for informational purposes only and does not constitute investment advice, a recommendation from any Goldman Sachs entity to take any particular action, or an offer or solicitation to purchase or sell any securities or financial products. This material may contain forward-looking statements. Past performance is not indicative of future results. Neither Goldman Sachs nor any of its affiliates make any representations or warranties, expressed or implied, as to the accuracy or completeness of the statements or information contained herein and disclaim any liability whatsoever for reliance on such information for any purpose. Each name of a third-party organization mentioned is the property of the company to which it relates is used here strictly for informational and identification purposes only and is not used to imply any ownership or license rights between any such company and Goldman Sachs.

A transcript is provided for convenience and may differ from the original video or audio content. Goldman Sachs is not responsible for any errors in the transcript. This material should not be copied, distributed, published, or reproduced in whole or in part or disclosed by any recipient to any other person without the express written consent of Goldman Sachs.

Disclosures applicable to research with respect to issuers, if any, mentioned herein are available through your Goldman Sachs representative or at
www.GS.com/research/hedge.html.

Goldman Sachs does not endorse any candidate or any political party.

Copyright 2026, Goldman Sachs, all rights reserved.
Learn more about your ad choices. Visit megaphone.fm/adchoices

Xaira Therapeutics is harnessing AI to fundamentally change how we discover and develop medicines, shortening the path from lab to clinic for previously "un-druggable" targets. Dr. Marc Tessier-Lavigne, co-founder, chairman, and CEO of Xaira Therapeutics, sits down with Sonia Gupta, co-head of Biotech Investment Banking at Goldman Sachs, to explore his journey from neuroscience to higher-education, the critical role of talent and purpose in building world-class organizations, and a roadmap for translating scientific insight into real-world impact. This session was recorded at the 2025 Goldman Sachs Builders and Innovators Summit on October 16, 2025. 

The opinions and views expressed herein are as of the date of publication, subject to change without notice, and may not necessarily reflect the institutional views of Goldman Sachs or its affiliates. The material provided is intended for informational purposes only, and does not constitute investment advice, a recommendation from any Goldman Sachs entity to take any particular action, or an offer or solicitation to purchase or sell any securities or financial products. This material may contain forward-looking statements. Past performance is not indicative of future results. Neither Goldman Sachs nor any of its affiliates make any representations or warranties, express or implied, as to the accuracy or completeness of the statements or information contained herein and disclaim any liability whatsoever for reliance on such information for any purpose. Each name of a third-party organization mentioned is the property of the company to which it relates, is used here strictly for informational and identification purposes only and is not used to imply any ownership or license rights between any such company and Goldman Sachs.

A transcript is provided for convenience and may differ from the original video or audio content. Goldman Sachs is not responsible for any errors in the transcript. This material should not be copied, distributed, published, or reproduced in whole or in part or disclosed by any recipient to any other person without the express written consent of Goldman Sachs.

Disclosures applicable to research with respect to issuers, if any, mentioned herein are available through your Goldman Sachs representative or at http://www.gs.com/research/hedge.html

Goldman Sachs does not endorse any candidate or any political party.

Copyright 2026, Goldman Sachs, all rights reserved.

Learn more about your ad choices. Visit megaphone.fm/adchoices